← All organizations
Highest phase reached
Phase 4
First clinical trial
Aug 1, 2005Last known activity
Apr 23, 2024
Timeline
1950s
- Jun 1, 1959
Jeil Pharmaceutical Co., Ltd.— Founded
Drugs by trial phase (42 distinct, 43 trials)
Phase 4 (8 own, 0 via acquisition)
Phase 3 (9 own, 0 via acquisition)
Phase 2 (17 own, 0 via acquisition)
Indications
Studied for
- Aneurysm
- Atherosclerosis
- Biliary Tract Neoplasms
- Carcinoma
- Carcinoma, Non-Small-Cell Lung
- Carotid Artery Diseases
- Cerebral Infarction
- Colorectal Neoplasms
- Coronary Aneurysm
- Coronary Artery Disease
- Diabetes Mellitus
- Diabetes Mellitus, Type 2
- Digestive System Neoplasms
- Dyslipidemias
- Esophageal Neoplasms
- Essential Hypertension
- Gastroesophageal Reflux
- Gastrointestinal Neoplasms
- Hyperlipidemias
- Hyperplasia
- Hypertension
- Ischemia
- Lower Urinary Tract Symptoms
- Lung Neoplasms
- Neoplasms
- Pancreatic Neoplasms
- Prostatic Hyperplasia
- Stomach Neoplasms
- Stroke
- Urinary Bladder, Overactive
Recent trials (44)
- NCT06431399Lead sponsorPhase 1Apr 23, 2024
- NCT06169059Lead sponsorPhase 1Oct 5, 2023
- NCT05820048CollaboratorPhase 4May 1, 2023
- NCT05296044Lead sponsorPhase 3Apr 5, 2022
- NCT06171880Lead sponsorPhase 1Feb 15, 2022
- NCT05101135Lead sponsorPhase 3Nov 8, 2021
- NCT04914221Lead sponsorPhase 1Mar 13, 2021
- NCT05172622Lead sponsorPhase 1Nov 24, 2020
- NCT04917315Lead sponsorPhase 3May 21, 2020
- NCT04282954Lead sponsorPhase 2Nov 15, 2019
- NCT03707899Lead sponsorPhase 1Dec 31, 2018
- NCT03690778Lead sponsorPhase 1Oct 31, 2018
- NCT03383042Lead sponsorPhase 1Dec 21, 2017
- NCT04335604CollaboratorPhase 1Dec 6, 2017
- NCT03362008Lead sponsorPhase 1Jul 6, 2017
Details
- Founded
- Seoul, KR Jun 1, 1959
- Last known activity
- Apr 23, 2024